IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q4 2018 Holdings

Filed 2019-02-14 | 3 holdings | $3.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MMA Cap Mgmt LLC(MMAC)COM55315D105$1.8K72,55251.3%
Onconova Therapeutics IncCOM PAR68232V405$1.7K816,27248.3%
Onconova Therapeutics Inc*W EXP 07/11/20268232V116$16390,6240.4%